Error
Jump to navigation
Jump to search
Subcategories
This category has the following 47 subcategories, out of 47 total.
C
Pages in category "Disease"
The following 200 pages are in this category, out of 24,470 total.
(previous page) (next page)1
- 11β-hydroxylase deficiency historical perspective
- 11β-hydroxylase deficiency overview
- 17 alpha-hydroxylase deficiency epidemiology and demographics
- 17 alpha-hydroxylase deficiency laboratory findings
- 17-beta-hydroxysteroid dehydrogenase deficiency (patient information)
- 17-beta-hydroxysteroid dehydrogenase deficiency case study one
- 17-beta-hydroxysteroid dehydrogenase deficiency causes
- 17-beta-hydroxysteroid dehydrogenase deficiency classification
- 17-beta-hydroxysteroid dehydrogenase deficiency cost-effectiveness of therapy
- 17-beta-hydroxysteroid dehydrogenase deficiency CT
- 17-beta-hydroxysteroid dehydrogenase deficiency differential diagnosis
- 17-beta-hydroxysteroid dehydrogenase deficiency epidemiology and demographics
- 17-beta-hydroxysteroid dehydrogenase deficiency future or investigational therapies
- 17-beta-hydroxysteroid dehydrogenase deficiency genotyping
- 17-beta-hydroxysteroid dehydrogenase deficiency historical perspective
- 17-beta-hydroxysteroid dehydrogenase deficiency history and symptoms
- 17-beta-hydroxysteroid dehydrogenase deficiency laboratory findings
- 17-beta-hydroxysteroid dehydrogenase deficiency medical therapy
- 17-beta-hydroxysteroid dehydrogenase deficiency molecular genetic studies
- 17-beta-hydroxysteroid dehydrogenase deficiency natural history, complications and prognosis
- 17-beta-hydroxysteroid dehydrogenase deficiency other diagnostic studies
- 17-beta-hydroxysteroid dehydrogenase deficiency other imaging findings
- 17-beta-hydroxysteroid dehydrogenase deficiency overview
- 17-beta-hydroxysteroid dehydrogenase deficiency pathophysiology
- 17-beta-hydroxysteroid dehydrogenase deficiency pelvic x ray
- 17-beta-hydroxysteroid dehydrogenase deficiency physical examination
- 17-beta-hydroxysteroid dehydrogenase deficiency primary prevention
- 17-beta-hydroxysteroid dehydrogenase deficiency risk factors
- 17-beta-hydroxysteroid dehydrogenase deficiency screening
- 17-beta-hydroxysteroid dehydrogenase deficiency secondary prevention
- 17-beta-hydroxysteroid dehydrogenase deficiency surgical therapy
- 17-beta-hydroxysteroid dehydrogenase deficiency ultrasound
- 17-beta-hydroxysteroid dehydrogenase deficiency x ray
2
- 2013 ACCF/AHA Guideline The Hospitalized Patient
- 21-hydroxylase deficiency
- 21-hydroxylase deficiency (patient information)
- 21-Hydroxylase Deficiency (patient information)
- 21-Hydroxylase Deficiency case study one
- 21-Hydroxylase Deficiency causes
- 21-hydroxylase deficiency causes
- 21-Hydroxylase Deficiency classification
- 21-hydroxylase deficiency classification
- 21-Hydroxylase Deficiency cost-effectiveness of therapy
- 21-Hydroxylase Deficiency CT
- 21-hydroxylase deficiency CT
- 21-Hydroxylase Deficiency differential diagnosis
- 21-hydroxylase deficiency differential diagnosis
- 21-hydroxylase deficiency electrocardiogram
- 21-Hydroxylase Deficiency epidemiology and demographics
- 21-hydroxylase deficiency epidemiology and demographics
- 21-Hydroxylase Deficiency future or investigational therapies
- 21-Hydroxylase Deficiency genotyping
- 21-Hydroxylase Deficiency historical perspective
- 21-hydroxylase deficiency historical perspective
- 21-Hydroxylase Deficiency history and symptoms
- 21-hydroxylase deficiency history and symptoms
- 21-Hydroxylase Deficiency laboratory findings
- 21-hydroxylase deficiency laboratory findings
- 21-Hydroxylase Deficiency medical therapy
- 21-hydroxylase deficiency medical therapy
- 21-Hydroxylase Deficiency molecular genetic studies
- 21-hydroxylase deficiency MRI
- 21-Hydroxylase Deficiency natural history, complications and prognosis
- 21-hydroxylase deficiency natural history, complications and prognosis
- 21-Hydroxylase Deficiency other diagnostic studies
- 21-hydroxylase deficiency other diagnostic studies
- 21-Hydroxylase Deficiency other imaging findings
- 21-hydroxylase deficiency other imaging findings
- 21-Hydroxylase Deficiency overview
- 21-hydroxylase deficiency overview
- 21-Hydroxylase Deficiency pathophysiology
- 21-hydroxylase deficiency pathophysiology
- 21-Hydroxylase Deficiency pelvic x ray
- 21-Hydroxylase Deficiency physical examination
- 21-hydroxylase deficiency physical examination
- 21-Hydroxylase Deficiency primary prevention
- 21-hydroxylase deficiency primary prevention
- 21-Hydroxylase Deficiency risk factors
- 21-hydroxylase deficiency risk factors
- 21-Hydroxylase Deficiency screening
- 21-hydroxylase deficiency screening
- 21-Hydroxylase Deficiency secondary prevention
- 21-hydroxylase deficiency secondary prevention
- 21-Hydroxylase Deficiency social issues
- 21-Hydroxylase Deficiency surgery
- 21-hydroxylase deficiency surgery
- 21-Hydroxylase Deficiency ultrasound
- 21-hydroxylase deficiency ultrasound
- 21-hydroxylase deficiency x ray
5
- 5-alpha-reductase deficiency
- 5-alpha-reductase deficiency (patient information)
- 5-alpha-reductase deficiency case study one
- 5-alpha-reductase deficiency causes
- 5-alpha-reductase deficiency classification
- 5-alpha-reductase deficiency cost-effectiveness of therapy
- 5-alpha-reductase deficiency CT
- 5-alpha-reductase deficiency differential diagnosis
- 5-alpha-reductase deficiency electrocardiogram
- 5-alpha-reductase deficiency epidemiology and demographics
- 5-alpha-reductase deficiency future or investigational therapies
- 5-alpha-reductase deficiency genotyping
- 5-alpha-reductase deficiency historical perspective
- 5-alpha-reductase deficiency history and symptoms
- 5-alpha-reductase deficiency laboratory findings
- 5-alpha-reductase deficiency medical therapy
- 5-alpha-reductase deficiency molecular genetic studies
- 5-alpha-reductase deficiency natural history, complications and prognosis
- 5-alpha-reductase deficiency other diagnostic studies
- 5-alpha-reductase deficiency other imaging findings
- 5-alpha-reductase deficiency overview
- 5-alpha-reductase deficiency pathophysiology
- 5-alpha-reductase deficiency pelvic x ray
- 5-alpha-reductase deficiency physical examination
- 5-alpha-reductase deficiency primary prevention
- 5-alpha-reductase deficiency risk factors
- 5-alpha-reductase deficiency screening
- 5-alpha-reductase deficiency secondary prevention
- 5-alpha-reductase deficiency surgery
- 5-alpha-reductase deficiency ultrasound
A
- Aagenaes syndrome
- AAOS classification of periprosthetic hip fracture
- Abdallat Davis Farrage syndrome
- Abdominal aortic aneurysm
- Abdominal aortic aneurysm (patient information)
- Abdominal aortic aneurysm abdominal ultrasound
- Abdominal aortic aneurysm abdominal x ray
- Abdominal aortic aneurysm case study one
- Abdominal aortic aneurysm classification
- Abdominal aortic aneurysm CT
- Abdominal aortic aneurysm CT scan
- Abdominal aortic aneurysm differential diagnosis
- Abdominal aortic aneurysm echocardiography and ultrasound
- Abdominal aortic aneurysm epidemiology and demographics
- Abdominal aortic aneurysm historical perspective
- Abdominal aortic aneurysm history and symptoms
- Abdominal aortic aneurysm medical therapy
- Abdominal aortic aneurysm MRI
- Abdominal aortic aneurysm natural history
- Abdominal aortic aneurysm natural history, complications and prognosis
- Abdominal aortic aneurysm other imaging findings
- Abdominal aortic aneurysm overview
- Abdominal aortic aneurysm pathophysiology
- Abdominal aortic aneurysm physical examination
- Abdominal aortic aneurysm prevention
- Abdominal aortic aneurysm primary prevention
- Abdominal aortic aneurysm risk factors
- Abdominal aortic aneurysm screening
- Abdominal aortic aneurysm surgery
- Abdominal aortic aneurysm ultrasound
- Abdominal aortic aneurysm x ray
- Abdominal pain duration critical pathways
- Abdominal wall defect
- Abnormal basal metabolic rate
- Abnormal cardiac rhythm
- Abnormalities in the cardiac rhythm
- Abnormality in the cardiac rhythm
- ABO incompatibility (patient information)
- Abscess
- Abscess (patient information)
- Absence of gluteal muscle
- Acalvaria
- Acanthocheilonemiasis
- Acanthocytosis
- Acanthocytosis (patient information)
- Acanthocytosis case study one
- Acanthocytosis causes
- Acanthocytosis chorea
- Acanthocytosis cost-effectiveness of therapy
- Acanthocytosis CT
- Acanthocytosis differential diagnosis
- Acanthocytosis epidemiology and demographics
- Acanthocytosis future or investigational therapies
- Acanthocytosis history and symptoms
- Acanthocytosis laboratory findings
- Acanthocytosis medical therapy
- Acanthocytosis MRI
- Acanthocytosis natural history, complications and prognosis
- Acanthocytosis other diagnostic studies
- Acanthocytosis other imaging findings
- Acanthocytosis overview
- Acanthocytosis pathophysiology
- Acanthocytosis physical examination
- Acanthocytosis prevention
- Acanthocytosis risk factors
- Acanthocytosis surgery
- ACC AHA guideline on the primary prevention of hypercholestrolemia
- ACC AHA guidelines for evaluation of unoperated patients with atrial septal defects
- ACC AHA recommendations for evaluation of the unoperated patient in atrial septal defect
- ACC/AHA guideline on the secondary prevention of hypercholestrolemia
- ACC/AHA recommendations for closure of patent ductus arteriosus
- ACC/AHA recommendations for evaluation of patients with unoperated patent ductus arteriosus
- ACC/AHA recommendations for reproduction in levo-transposition of the great arteries
- ACC/AHA recommendations for surgical intervention in L-transposition of the great arteries
- Accessory pancreas
- Achalasia
Media in category "Disease"
This category contains only the following file.
-
NCEP guidelines.png 960 × 720; 14 KB
